4924 J ournal of Medicinal Chemistry, 2003, Vol. 46, No. 23
Matsuno et al.
(19) Hart, C. E.; Kraiss, L. W.; Vergel, S.; Gilbertson, D.; Kenagy,
R.; Kirkman, T.; Crandall, D. L.; Tickle, S.; Finney, H.; Yarran-
ton, G.; Clowes, A. W. PDGFâ Receptor Blockade Inhibits
Intimal Hyperplasia in the Baboon. Circulation 1999, 99, 564-
569.
(20) Sirois, M. G.; Simons, M.; Edelman, E. R. Antisense Oligonucle-
otide Inhibition of PDGFR-â Receptor Subunit Expression
Directs Suppression of Intimal Thickening. Circulation 1997,
95, 669-676.
(21) Matsuno, K.; Ichimura, M.; Nakajima, T.; Tahara, K.; Fujiwara,
S.; Kase, H.; Giese, N. A.; Pandey, A.; Scarborough, R. M.; Yu,
J .-C.; Lokker, N. A.; Irie, J .; Tsukuda, E.; Ide, S.-i.; Oda, S.;
Nomoto, Y. Potent and Selective Inhibitors of Platelet-Derived
Growth Factor Receptor Phosphorylation. 1. Synthesis and
Structure-Activity Relationship, and Biological Effects of a New
Class of Quinazoline Derivatives. J . Med. Chem. 2002, 45, 3057-
3066.
(22) Matsuno, K.; Nakajima, T.; Ichimura, M.; Giese, N. A.; Yu, J .-
C.; Lokker, N. A.; Ide, S.-i.; Oda, S.; Nomoto, Y. Potent and
Selective Inhibitors of PDGF Receptor Phosphorylation. 2.
Synthesis, Structure Activity Relationship, Improvement of
Aqueous Solubility and Biological Effects of 4-[4-(N-Substituted
(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline De-
rivatives. J . Med. Chem. 2002, 45, 4513-4523.
(23) Matsuno, K.; Seishi, T.; Nakajima, T.; Ichimura, M.; Giese, N.
A.; Yu, J .-C.; Oda, S.; Nomoto, Y. Potent and Selective Inhibitors
of Platelet-Derived Growth Factor Receptor Phosphorylation.
Part 4. Structure-Activity Relationships for Substituents on the
Quinazoline Moiety of 4-[4-(N-Substituted (thio)carbamoyl)-1-
piperazinyl]-6,7-dimethoxyquinazoline Derivatives. Bioorg. Med.
Chem. Lett. 2003, 13, 3001-3004.
(24) Matsuno, K.; Ichimura, M.; Nomoto, Y.; Fujiwara, S.; Ide, S.-i.;
Tsukuda, E.; Irie, J .; Oda, S. Nitrogen-Containing Heterocyclic
Compounds. PCT Int. Appl. WO9814431, April 9, 1998; Chem.
Abstr. 1998, 128, 257447.
(25) Matsuno, K.; Nomoto, Y.; Ichimura, M.; Ide, S.-i.; Oda, S.
Nitrogen-Containing Heterocyclic Compounds. PCT Int. Appl.
WO9951582, October 14, 1999; Chem. Abstr. 1999, 131, 271888.
(26) Matsuno, K.; Nakajima, T.; Tahara, K.; Seishi, T.; Fujiwara, S.;
Ichimura, M.; Giese, N. A.; Yu, J .-C.; Irie, J .; Tsukuda, E.; Ide,
S.-i.; Oda, S.; Nomoto, Y. Synthesis and Structure Activity
Relationships of PDGF Receptor Phosphorylation Inhibitor-1.
Presented at the 18th Symposium on Medicinal Chemistry, 7th
Annual Meeting of Division of Medicinal Chemistry, The Phar-
maceutical Society of J apan, Kyoto, J apan, November 25-27,
1998; Paper 2P-05.
(27) Matsuno, K.; Nakajima, T.; Tahara, K.; Fujiwara, S.; Ichimura,
M.; Giese, N. A.; Yu, J .-C.; Irie, J .; Tsukuda, E.; Ide, S.-i.; Oda,
S.; Nomoto, Y. Selective Inhibitor of PDGF Receptor Phospho-
rylation. Synthesis, Structure Activity Relationships and Bio-
logical Effects. Presented at the 217th National Meeting of the
American Chemical Society, Anaheim, CA, March 21-25, 1999;
Paper MEDI 61.
(28) Yu, J .-C.; Lokker, N.; Hollenbach, S.; Apatira, M.; Li, J .; Betz,
A.; Sedlock, D.; Oda, S.; Nomoto, Y.; Matsuno, K.; Ide, S.;
Tsukuda, E.; Giese, N. A. Efficacy of the Novel Selective Platelet-
Derived Growth Factor Receptor Antagonist CT52923 on Cel-
lular Proliferation, Migration, and Suppression of Neointima
Following Vascular Injury. J . Pharmacol. Exp. Ther. 2001, 298,
1172-1178.
(29) Lokker, N. A.; Sullivan, C. M.; Hollenbach, S. J .; Israel, M. A.;
Giese, N. A. Platelet-Derived Growth Factor (PDGF) Autocrine
Signaling Regulates Survival and Mitogenic Pathways in Glio-
blastoma Cells: Evidence That the Novel PDGF C and PDGF
D Ligands May Play a Role in the Development of Brain Tumors.
Cancer Res. 2002, 62, 3729-3735.
(30) Giese, N. A.; Lokker, N. A.; Yu, J .-C.; Matsuno, K.; Ichimura,
M.; Oda, S.; Scarborough, R. M.; Pandey, A. Development of
Antagonists of the Platelet-Derived Growth Factor Receptor
Family. Oncol. Spectrum 2001, 2, 550-556.
(31) Leonard, N. J .; Morrice, A. G.; Sprecker, M. A. Linear Benzoad-
enine. A Streched-Out Analog of Adenine. J . Org. Chem. 1975,
40, 356-363.
(32) Machii, D.; Matsuno, K.; Kinoshita, I.; Nomoto, Y.; Takai, H.;
Ohno, T.; Nagashima, K.; Ishikawa, T.; Yamada, K. Preparation
of Imidazoquinazoline Derivatives Having Cyclic Guanosine
3′,5′-Monophosphate (cGMP)-Specific Phosphoesterase Inhibitor
Activity. PCT Int. Appl. WO9506648, March 9, 1995; Chem.
Abstr. 1995, 123, 256749p.
(33) Pandey, A.; Volkots, D. L.; Seroogy, J . M.; Rose, J . W.; Yu, J .-
C.; Lambing, J . L.; Hutchaleelaha, A.; Hollenbach, S. J .; Abe,
K.; Giese, N. A.; Scarborough, R. M. Identification of Orally
Active, Potent, and Selective 4-Piperazinylquinazolines as An-
tagonists of the Platelet-Derived Growth Factor Receptor Ty-
rosine Kinase Family. J . Med. Chem. 2002, 45, 3772-3793.
(34) Bridges, A. J . Chemical Inhibitors of Protein Kinases. Chem.
Rev. 2001, 101, 2541-2571.
compounds. This material is available free of charge via the
Internet at http://pubs.acs.org.
Refer en ces
(1) Fretto, L. J .; Snape, A. J .; Tomlinson, J . E.; Seroogy, J . J .; Wolf,
D. L.; LaRochelle, W. J .; Giese, N. A. Mechanism of Platelet-
Derived Growth Factor (PDGF) AA, AB, and BB Binding to
Alpha and Beta PDGF Receptor. J . Biol. Chem. 1993, 268, 3625-
3631.
(2) Heldin, C. H.; Ostman, A.; Eriksson, A.; Siegbahn, A.; Claesson-
Welsh, L.; Westermark, B. Platelet-Derived Growth Factor:
Isoform-Specific Signalling via Heterodimeric or Homodimeric
Receptor Complexes. Kidney Int. 1992, 41, 571-574.
(3) Herren, B.; Rooney, B.; Weyer, K. A.; Iberg, N.; Schmid, G.; Pech,
M. Dimerization of Extracellular Domains of Platelet-Derived
Growth Factor Receptors. A Revised Model of Receptor-Ligand
Interaction. J . Biol. Chem. 1993, 268, 15088-15095.
(4) Stoddard, B. L.; Biemann, H. P.; Koshland, D. E., J r. Receptors
and Transmembrane Signaling. Cold Spring Harbor Symp.
Quant. Biol. 1992, 57, 1-15.
(5) Bonner, J . C.; Lindroos, P. M.; Rice, A. B.; Moomaw, C. R.;
Morgan, D. L. Induction of PDGF Receptor-alpha in Rat Myo-
fibroblasts during Pulmonary Fibrogenesis in Vivo. Am. J .
Physiol.: Lung Cell. Mol. Physiol. 1998, 274, L72-L80.
(6) Friedman, S. L. Molecular Regulation of Hepatic Fibrosis, an
Integrated Cellular Response to Tissue Injury. J . Biol. Chem.
2000, 275, 2247-2250.
(7) Gesualdo, L.; Pinzani, M.; Floriano, J . J .; Hassan, M. O.; Nagy,
N. U.; Schena, F. P.; Emancipator, S. N.; Abboud, H. E. Platelet-
Derived Growth Factor Expression in Mesangial Proliferative
Glomerulonephritis. Lab. Invest. 1991, 65, 160-167.
(8) Heldin, C. H.; Westermark, B. Platelet-Derived Growth Factor:
Mechanism of Action and Possible in Vivo Function. Cell Regul.
1990, 1, 555-566.
(9) Iida, H.; Seifert, R.; Alpers, C. E.; Gronwald, R. G. K.; Phillips,
P. E.; Pritzl, P.; Gordon, K.; Gown, A. M.; Ross, R.; Bowen-Pope,
D. F.; J ohnson, R. J . Platelet-Derived Growth Factor (PDGF)
and PDGF Receptor Are Induced in Mesangial Proliferative
Nephritis in the Rat. Proc. Natl. Acad. Sci. U.S.A. 1991, 88,
6560-6564.
(10) J ohnson, R. J .; Raines, E. W.; Floege, J .; Yoshimura, A.; Pritzl,
P.; Alpers, C.; Ross, R. Inhibition of Mesangial Cell Proliferation
and Matrix Expansion in Glomerulonephritis in the Rat by
Antibody to Platelet-Derived Growth Factor. J . Exp. Med. 1992,
175, 1413-1416.
(11) Rice, A. B.; Moomaw, C. R.; Morgan, D. L.; Bonner, J . C. Specific
Inhibitors of Platelet-Derived Growth Factor or Epidermal
Growth Factor Receptor Tyrosine Kinase Reduce Pulmonary
Fibrosis in Rats. Am. J . Pathol. 1999, 155, 213-221.
(12) Ross, R.; Masuda, J .; Raines, E. W.; Gown, A. M.; Katsuda, S.;
Sasahara, M.; Malden, L. T.; Masuko, H.; Sato, H. Localization
of PDGF-B Protein in Macrophages in All Phases of Atherogen-
esis. Science 1990, 248, 1009-1012.
(13) Wilcox, J . N.; Smith, K. M.; Williams, L. T.; Schwartz, S. M.;
Gordon, D. Platelet-Derived Growth Factor mRNA Detection in
Human Atherosclerotic Plaques by in Situ Hybridization. J . Clin.
Invest. 1988, 82, 1134-1143.
(14) Wong, L.; Yamasaki, G.; J ohnson, R. J .; Friedman, S. L.
Induction of Beta-Platelet-Derived Growth Factor Receptor in
Rat Hepatic Lipocytes during Cellular Activation in Vivo and
in Culture. J . Clin. Invest. 1994, 94, 1563-1569.
(15) Yagi, M.; Kato, S.; Kobayashi, Y.; Kobayashi, N.; Iinuma, N.;
Nakamura, K.; Kubo, K.; Ohyama, S.; Murooka, H.; Shimizu,
T.; Nishitoba, T.; Osawa, T.; Nagano, N. Beneficial Effects of a
Novel Inhibitor of Platelet-Derived Growth Factor Receptor
Autophosphorylation in the Rat with Mesangial Proliferative
Glomerulonephritis. Gen. Pharmacol. 1998, 31, 765-773.
(16) Bilder, G.; Wentz, T.; Leadley, R.; Amin, D.; Byan, L.; O’Conner,
B.; Needle, S.; Galczenski, H.; Bostwick, J .; Kasiewski, C.; Myers,
M.; Spada, A.; Merkel, L.; Ly, C.; Persons, P.; Page, K.; Perrone,
M.; Dunwiddie, C. Restenosis Following Angioplasty in the
Swine Coronary Artery Is Inhibited by an Orally Active PDGF-
Receptor Tyrosine Kinase Inhibitor, RPR101511A. Circulation
1999, 99, 3292-3299.
(17) Ferns, G. A.; Raines, E. W.; Sprugel, K. H.; Motani, A. S.; Reidy,
M. A.; Ross, R. Inhibition of Neointimal Smooth Muscle Ac-
cumulation after Angioplasty by an Antibody to PDGF. Science
1991, 253, 1129-1132.
(18) Giese, N. A.; Marijianowski, M. M. H.; McCook, O.; Hancock,
A.; Ramakrishnan, V.; Fretto, L. J .; Chen, C.; Kelly, A. B.; Koziol,
J . A.; Wilcox, J . N.; Hanson, S. R. The Role of Alpha and Beta
Platelet-Derived Growth Factor Receptor in the Vascular Re-
sponse to Injury in Nonhuman Primates. Arterioscler., Thromb.,
Vasc. Biol. 1999, 19, 900-909.